The effect of exendin-4 on changes in intracellular signaling by Ang II was also examined to provide a possible mechanism by which exendin-4 may be used as a pharmacotherapeutic agent for the prevention of hypertension and atherosclerosis independent of its blood glucose lowering effect. The gene discussed is AGT; the disease is hypertensive disorder.